← Home
📢 Press Releases
| Date | Press release |
|---|---|
| 2026-04-07 06:50:00 | When Every Beat Matters, Bd Helps Clinicians Eliminate Blind Spots With Continuous, Noninvasive Blood Pressure Insight New hemosphere stream™ module expands access to continuous, noninvasive arterial waveform data across compatible bedside monitors and broader care settings, giving more clinicians real-time insight into more patients. franklin lakes, n.j. |
| 2026-04-01 05:00:00 | Bd Launches Ai-enabled Medication Dispensing System To The European Market Advanced automation and connected data capabilities strengthen medication inventory control and enhance safety across pharmacy settings. franklin lakes, n.j. |
| 2026-03-02 06:50:00 | Bd Pioneers New Standard In Surgical Safety With Fda-cleared Surgiphor™ 1000ml For Wound Irrigation The first and only innovation of its kind to receive 510(k) clearance, surgiphor™ 1000ml empowers surgical teams with a consistent, antimicrobial solution designed to improve patient care and operating room (or) efficiency franklin lakes, n.j., march 2, 2026 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced it received 510(k) clearance from the u.s. food and drug administration (fda) for the surgiphor™ 1000ml. |
| 2026-02-25 16:15:00 | Becton, Dickinson And Company Announces Pricing Of The Tender Offers And Amounts Accepted For Purchase Franklin lakes, n.j., feb. 25, 2026 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx) (the ’company’ or ’bd’), a leading global medical technology company, today announced the consideration payable in connection with its previously announced tender offers (as defined below) to purchase for cash up to $2,000,000,000 aggregate purchase price, excluding the applicable accrued interest (as defined below) (which, subject to applicable law, may be increased or decreased in the company’s sole discretion, the ’aggregate offer cap’) of its (i) 6.700% senior notes due 2026, (ii) 7.000% senior debentures due 2027, (iii) 6.700% senior debentures due 2028, (iv) 6.000% senior notes due 2039, (v) 4.875% senior notes due 2044, (vi) 4.669% senior notes due 2047, (vii) 5.000% senior notes due 2040, (viii) 4.685% senior notes due 2044 (the ’4.685% senior notes’), (ix) 5.081% senior notes due 2029, (x) 3.794% senior notes due 2050, (xi) 4.874% senior notes due 2029, (xii) 4.693% senior notes due 2028, (xiii) 3.700% senior notes due 2027, (xiv) 5.110% senior notes due 2034, and (xv) 4.298% senior notes due 2032 (collectively, the ’securities’ and each a ’series’), in the order of priority set forth in the table below (each, an ’acceptance priority level’), subject to an aggregate principal amount of each series of securities that does not exceed the applicable offer subcap, if any, set forth in the table below (each, an ’offer subcap’) (collectively, the ’tender offers’); provided that the company will only accept for purchase up to an aggregate purchase price, excluding the applicable accrued interest, of all series of securities that does not exceed the aggregate offer cap. |
| 2026-02-25 08:00:00 | Becton, Dickinson And Company Announces Early Tender Results And Upsizing Of Offer Subcap And Aggregate Offer Cap Franklin lakes, n.j., feb. 25, 2026 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx) (the ’company’ or ’bd’), a leading global medical technology company, today announced the early tender results for its previously announced tender offers (as defined below) to purchase for cash certain of its outstanding debt securities listed in the table below. |
| 2026-02-23 16:15:00 |
|
| 2026-02-23 06:50:00 |
|
| 2026-02-19 16:15:00 |
|
| 2026-02-10 13:00:00 |
|
| 2026-02-09 08:40:00 |
|
| 2026-02-09 06:30:00 |
|
| 2026-01-29 06:50:00 |
|
| 2026-01-27 16:15:00 |
|
| 2026-01-27 09:26:00 |
|
| 2026-01-27 09:25:00 |
|
📰 Browse additional press releases for Becton Dickinson and Company!
Sign up for free or log in🚀 Don’t miss "The Checklist Value Investor — A Smarter Way to Pick Stocks" — free!